ANDA 76202, held by Gavis Pharms. Acetaminophen; Pentazocine Hydrochloride.
As of Nov 16, 2026, ANDA 76202 (Acetaminophen And Pentazocine Hydrochloride), held by Gavis Pharms, was first approved by FDA on Aug 2, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 2, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acetaminophen And Pentazocine Hydrochloride650MG;EQ 25MG BASE ยท tablet;oral | Acetaminophen; Pentazocine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters